Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells

PLoS ONE

Volumn 13, Issue 1, 2018, Pages

  Hwang, HyunTae V ^a   Tran, Darlene Thuy ^a   Rebuffatti, Michelle Nicole ^a   Li, Chin Shang ^a   Knowlton, Anne A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; HYPERIN; QUERCETIN;

ADULT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SENESCENCE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CELL AGING; CYTOLOGY; DRUG EFFECTS; VASCULAR ENDOTHELIUM;

ADULT; CELL PROLIFERATION; CELLULAR SENESCENCE; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; QUERCETIN;

EID: 85040344727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190374     Document Type: Article

References (49)

1. D’Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia. 2015; 106:256–71. http://dx.doi.org/10.1016/j.fitote.2015.09.018. https://doi.org/10.1016/j.fitote.2015.09.018PMID: 26393898
2. Scambia G, Ranelletti F, Panici PB, Piantelli M, Bonanno G, De Vincenzo R, et al. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. British journal of cancer. 1990; 62(6):942. PMID: 2257224
3. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, et al. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. British journal of pharmacology. 2010; 159(6):1312–25. Epub 2010/02/13. https://doi.org/10.1111/j.14765381.2009.00632.x PMID: 20148891; PubMed Central PMCID: PMCPmc2848935.
4. Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem. 2011; 22(3):293–9. Epub 2010/06/29. https://doi.org/10.1016/j.jnutbio.2010.02.008 PMID: 20579867.
5. Boots AW, Haenen GRMM, Bast A. Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology. 2008; 585(2–3):325–37. http://dx.doi.org/10.1016/j.ejphar.2008.03.008. https://doi.org/10.1016/j.ejphar.2008.03.008 PMID: 18417116
6. Dabbagh-Bazarbachi H, Clergeaud G, Quesada IM, Ortiz M, O’Sullivan CK, Fernández-Larrea JB. Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1–6 cells to a liposome model. Journal of Agricultural and Food Chemistry. 2014; 62(32):8085–93. https://doi.org/10.1021/jf5014633PMID: 25050823
7. Matsuo M, Sasaki N, Saga K, Kaneko T. Cytotoxicity of flavonoids toward cultured normal human cells. Biological & pharmaceutical bulletin. 2005; 28(2):253–9. Epub 2005/02/03. PMID: 15684479.
8. Lee J-C, Kim J, Park J-K, Chung G-H, Jang Y-S. The antioxidant, rather than prooxidant, activities of quercetin on normal cells:: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Experimental Cell Research. 2003; 291(2):386–97. http://dx.doi.org/10.1016/S0014-4827(03)00410-5. PMID: 14644160
9. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of gen-otoxic/carcinogenic properties. Food and Chemical Toxicology. 2007; 45(11):2179–205. http://dx.doi.org/10.1016/j.fct.2007.05.015. https://doi.org/10.1016/j.fct.2007.05.015 PMID: 17698276
10. Liu Z, Tao X, Zhang C, Lu Y, Wei D. Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. Biomedicine & Pharmacotherapy. 2005; 59(9):481–90. http://dx.doi.org/10.1016/j.biopha.2005.06.009.
11. Boukes GJ, van de Venter M. The apoptotic and autophagic properties of two natural occurring pro-drugs, hyperoside and hypoxoside, against pancreatic cancer cell lines. Biomedicine & Pharmacotherapy. 2016; 83:617–26. http://dx.doi.org/10.1016/j.biopha.2016.07.029.
12. Bernatoniene J, Masteikova R, Majiene D, Savickas A, Kevelaitis E, Bernatoniene R, et al. Free radical-scavenging activities of Crataegus monogyna extracts. Medicina (Kaunas, Lithuania). 2008; 44(9):706–12. Epub 2008/10/31. PMID: 18971609.
13. Li Z-l, Liu J-c, Hu J, Li X-q, Wang S-w, Yi D-h, et al. Protective effects of hyperoside against human umbilical vein endothelial cell damage induced by hydrogen peroxide. Journal of Ethnopharmacology. 2012; 139(2):388–94. http://dx.doi.org/10.1016/j.jep.2011.11.020. https://doi.org/10.1016/j.jep.2011.11.020 PMID: 22120016
14. Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging cell. 2015; 14(4):644–58. https://doi.org/10.1111/acel.12344 PMID: 25754370
15. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685–705. Epub 2012/11/13. https://doi.org/10.1146/annurev-physiol-030212-183653 PMID: 23140366.
16. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006; 5(2):187–95. Epub 2006/04/22. https://doi.org/10.1111/j.1474-9726.2006.00199.x PMID: 16626397.
17. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008; 129(7–8):467–74. Epub 2008/05/27. https://doi.org/10.1016/j.mad.2008.04.001 PMID: 18502472; PubMed Central PMCID: PMCPMC3297662.
18. Tan PH, Chan C, Xue SA, Dong R, Ananthesayanan B, Manunta M, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 2004; 173(2):171–83. http://dx.doi.org/10.1016/j.atherosclerosis.2003.12.011. https://doi.org/10.1016/j.atherosclerosis.2003.12.011 PMID: 15064090
19. McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK. MicroRNA profiling of diverse endothelial cell types. BMC medical genomics. 2011; 4(1):78.
20. Rajavashisth T, Andalibi A, Territo M, Berliner J, Navab M. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990; 344(6263):254. https://doi.org/10.1038/344254a0 PMID: 1690354
21. Malavolta M, Costarelli L, Giacconi R, Basso A, Piacenza F, Pierpaoli E, et al. Changes in Zn homeostasis during long term culture of primary endothelial cells and effects of Zn on endothelial cell senescence. Experimental Gerontology. 2017; 99(Supplement C):35–45. https://doi.org/10.1016/j.exger.2017.09.006.
22. Heron M. Deaths: leading causes for 2014. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2016; 65 (5):1–96. Epub 2016/07/06. PMID: 27376998.
23. Freund A, Laberge R-M, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. Molecular biology of the cell. 2012; 23(11):2066–75. https://doi.org/10.1091/mbc.E11-10-0884 PMID: 22496421
24. Bancirova M. Changes of the quercetin absorption spectra in dependence on solvent. Chemistry Journal. 2015; 1:31–4.
25. Abcam. Abcam; [cited 2017 August 4]. Available from: http://www.abcam.com/quercetin-ab120247.html.
26. Samuel T, Fadlalla K, Turner T, Yehualaeshet TE. The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle. Nutrition and cancer. 2010; 62 (8):1025–35. doi: 10.1080/01635581.2010.492087. PMC3021775. PMID: 21058190
27. Duo J, Ying GG, Wang GW, Zhang L. Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation. Molecular medicine reports. 2012; 5(6):1453–6. Epub 2012/03/27. https://doi.org/10.3892/mmr.2012.845 PMID: 22447039.
28. Stice JP, Chen L, Kim SC, Jung JS, Tran AL, Liu TT, et al. 17beta-estradiol, aging, inflammation, and the stress response in the female heart. Endocrinology. 2011; 152(4):1589–98. Epub 2011/02/10. https://doi.org/10.1210/en.2010-0627 PMID: 21303943; PubMed Central PMCID: PMCPMC3060632.
29. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-[beta]gal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protocols. 2009; 4(12):1798–806. https://doi.org/10.1038/nprot.2009.191 PMID: 20010931
30. Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, et al. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Molecular and cellular biology. 2000; 20(8):2803–8. PMC85496. PMID: 10733583
31. Avci CB, Yilmaz S, Dogan ZO, Saydam G, Dodurga Y, Ekiz HA, et al. Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells. Hematology. 2011; 16(5):303–7. https://doi.org/10.1179/102453311X13085644680104 PMID: 21902895
32. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by down-regulation of HSF1. Biochemical and Biophysical Research Communications. 1995; 208(3):1099–105. http://dx.doi.org/10.1006/bbrc.1995.1447. https://doi.org/10.1006/bbrc.1995.1447 PMID: 7702609
33. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat Shock Factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell. 2007; 130(6):1005–18. Epub 2007/09/25. https://doi.org/10.1016/j.cell.2007.07. 020 PMID: 17889646; PubMed Central PMCID: PMCPMC2586609.
34. Nishizawa J, Nakai A, Matsuda K, Komeda M, Ban T, Nagata K. Reactive oxygen species play an important role in the activation of Heat Shock Factor 1 in ischemic-reperfused heart. Circulation. 1999; 99(7):934–41. https://doi.org/10.1161/01.cir.99.7.934 PMID: 10027818
35. Wang J, He H, Yu L, Xia HH-x, Lin MC, Gu Q, et al. HSF1 down-regulates XAF1 through transcriptional regulation. Journal of Biological Chemistry. 2006; 281(5):2451–9. https://doi.org/10.1074/jbc. M505890200 PMID: 16303760
36. Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. International Journal of Cell Biology. 2010; 2010:23. https://doi.org/10.1155/2010/214074 PMID: 20182529
37. Kim G, Meriin AB, Gabai VL, Christians E, Benjamin I, Wilson A, et al. The heat shock transcription factor Hsf1 is downregulated in DNA damage–associated senescence, contributing to the maintenance of senescence phenotype. Aging cell. 2012; 11(4):617–27. https://doi.org/10.1111/j.1474-9726.2012.00827.x PMID: 22510478
38. Luce MC, Cristofalo VJ. Reduction in heat shock gene expression correlates with increased thermosen-sitivity in senescent human fibroblasts. Experimental Cell Research. 1992; 202(1):9–16. http://dx.doi.org/10.1016/0014-4827(92)90398-R. PMID: 1380923
39. Gutsmann-Conrad A, Heydari AR, You S, Richardson A. The expression of Heat Shock Protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. Experimental Cell Research. 1998; 241(2):404–13. http://dx.doi.org/10.1006/excr.1998.4069. https://doi.org/10.1006/excr.1998.4069 PMID: 9637782
40. Anckar J, Sistonen L. Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annual review of biochemistry. 2011; 80:1089–115. Epub 2011/03/23. https://doi.org/10.1146/annurev-biochem-060809-095203 PMID: 21417720.
41. Shringarpure R, Davies KJA. Protein turnover by the proteasome in aging and disease. Free Radical Biology and Medicine. 2002; 32(11):1084–9. http://dx.doi.org/10.1016/S0891-5849(02)00824-9. PMID: 12031893
42. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479(7372):232–6. http://www.nature.com/nature/journal/v479/n7372/abs/nature10600.html#supplementaryinformation. https://doi.org/10.1038/nature10600 PMID: 22048312
43. Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016; 15 (3):428–35. https://doi.org/10.1111/acel.12445 PMID: 26711051
44. Wang Y, Chang J, Liu X, Zhang X, Zhang S, Zhang X, et al. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY). 2016; 8(11):2915–26. doi: 10. 18632/aging.101100. PMC5191878. PMID: 27913811
45. Fuhrmann-Stroissnigg H, Ling YY, Zhao J, McGowan SJ, Zhu Y, Brooks RW, et al. Identification of HSP90 inhibitors as a novel class of senolytics. Nature Communications. 2017; 8:422. doi: 10.1038/ s41467-017-00314-z. PMC5583353. PMID: 28871086
46. Powers MV, Valenti M, Miranda S, Maloney A, Eccles SA, Thomas G, et al. Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX. Oncotarget. 2013; 4(11):1963–75. PMC3875762. https://doi.org/10.18632/oncotarget.1419 PMID: 24185264
47. Kim HR, Kang HS, Kim HD. Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells. IUBMB Life. 1999; 48(4):429–33. https://doi.org/10.1080/ 713803536 PMID: 10632574
48. Conde R, Belak ZR, Nair M, O’Carroll RF, Ovsenek N. Modulation of Hsf1 activity by novobiocin and geldanamycin. Biochemistry and Cell Biology. 2009; 87(6):845–51. https://doi.org/10.1139/o09-049PMID: 19935870
49. Wang L, Yue Z, Guo M, Fang L, Bai L, Li X, et al. Dietary flavonoid hyperoside induces apoptosis of activated human LX-2 hepatic stellate cell by suppressing canonical NF-κB signaling. BioMed Research International. 2016; 2016:1068528. doi: 10.1155/2016/1068528. PMC4826685. PMID: 27110557